Learn more

SEARLE & CO

Overview
  • Total Patents
    8,529
About

SEARLE & CO has a total of 8,529 patent applications. Its first patent ever was published in 1926. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are UPJOHN CO, EISAI CO LTD and ASTRA PHARMA INC.

Patent filings per year

Chart showing SEARLE & COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Talley John J 368
#2 Mueller Richard A 312
#3 Getman Daniel P 233
#4 Hanson Gunnar J 228
#5 Decrescenzo Gary A 222
#6 Freskos John N 212
#7 Vazquez Michael L 210
#8 Weier Richard M 208
#9 Collins Paul W 187
#10 Reitz David B 176

Latest patents

Publication Filing date Title
US2005267171A1 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US2005032795A1 2-Amino-benzoxazinones for the treatment of herpes simplex virus
AU2004210578A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
AU2004203284A1 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
AU2004201161A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
AU2004200675A1 Substituted benzopyran analogs for the treatment of inflammation
US2005267302A1 Eplerenone crystalline form exhibiting enhanced dissolution rate
US2004102424A1 Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
AU2003252266A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
US6887991B1 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
US6861539B1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US2005250748A1 Combination therapy of angiotensin converting enzyme inhibitor and eplerenone for treatment of cardiovascular disease
US2004204367A1 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis
US6716991B1 Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
US2004121989A1 Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension
US2003220312A1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of cardiovascular disorders
CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
US2003144213A1 Combination therapy of angiotensin converting enzyme inhibitor, side-effect reduced amount of aldosterone antagonist and diuretic for treatment of cardiovascular disease
US2003207813A1 Retroviral protease inhibitor combinations
US2003050330A1 4,5-subtstituted imdazolyl compounds for the treatment of inflammation